期刊文献+

肺结核并发糖尿病患者外周血白细胞介素-22含量检测

Expression and Clinical Significance of Serum IL-22 on Patients with Pulmonary Tuberculosis and Diabetes Mellitus
下载PDF
导出
摘要 目的:检测肺结核并发糖尿病(PPTDM)患者外周血血清 IL-22含量并分析其意义。方法 ELISA 检测30例PPTDM 患者、30例肺结核(PTB)患者、30例糖尿病(DM)患者和30例健康志愿者(HV)血清 IL-22含量并分析其意义。结果PPTDM 组血清 IL-22含量(54.4±4.81 pg/ml)显著低于 DM 组(72.36±5.12 pg/ml)和 HV 组(68.32±3.08 pg/ml),差异均有统计学意义(t=2.557,P =0.013;t =2.437,P =0.018)。PPTDM 组血清 IL-22含量高于 PTB 组(45.36±5.88 pg/ml),但差异无统计学意义(t=1.190,P =0.239)。不同形式肺结核并发糖尿病患者血清 IL-22含量检测结果中,先患肺结核后患糖尿病(PTB-DM)组血清 IL-22含量(64.62±8.59 pg/ml)显著高于先患糖尿病后患肺结核(DM-PTB)组(44.21±2.68 pg/ml),差异有统计学意义(t =2.267,P =0.031)。结论IL-22在 PPTDM 疾病发生中可能具有重要作用。 Objective To study serum IL-22 levels in patients with pulmonary tuberculosis and diabetes mellitus (PPTDM) and to analysis their clinical significance.Methods ELISA was used to detect serum IL-22 levels in 30 cases PPTDM pa-tients,30 cases pulmonary tuberculosis (PTB)patients,30 cases diabetes mellitus (DM)patients and 30 cases healthy vol-unteers (HV).Results Serum IL-22 levels of PPTDM patients (54.4±4.81 pg/ml)were significantly lower than those in diabetes mellitus (DM)patients (72.36±5.12 pg/ml)and healthy volunteers (HV)(68.32±3.08 pg/ml)(t=2.557,P =0.013;t=2.437,P =0.018),respectively.There was no significantly different of serum IL-22 levels between PPTDM and PTB patients (t=1.190,P =0.239).Serum IL-22 levels of diabetes mellitus coincident with pulmonary tuberculosis (DM-PTB)patients (64.62±8.59 pg/ml)were significantly higher than those in pulmonary tuberculosis coincident with diabetes mellitus (PTB-DM)patients (44.21±2.68 pg/ml)(t=2.267,P =0.031).Conclusion IL-22 may play an important role in PPTDM development.
出处 《现代检验医学杂志》 CAS 2015年第4期155-157,共3页 Journal of Modern Laboratory Medicine
基金 广东省医学科研基金资助项目(B2013427),东莞市科技计划项目(201450715200503).
关键词 肺结核 糖尿病 白细胞介素-22 pulmonary tuberculosis diabetes mellitus IL-22
  • 相关文献

参考文献7

  • 1黄建飞.肺结核合并糖尿病治疗进展[J].中国药物经济学,2013,(2):365-368.
  • 2Kant S, Lata H, Natu SM, et al. Diabetes mellitus with pulmonary tuberculosis-a double trouble[J]. J Indian Med Assoc, 2013,111 (3) .. 187-191.
  • 3Yang XY, Zheng SG. Interleukin-22: a likely target for treatment of autoimmune diseases[J]. Autoimmun Rev,2014,13(6) .. 615-620.
  • 4Qu N,Xu ML,Mizoguchi I,et al. Pivotal roles of T- helper 17-related cytokines, IL-17, IL-22 and IL-23, in inflammatory diseases [J]. Clin Dev Immunol, 2013 (2013) : 968549.
  • 5Yao SY, Huang D, Chen CY; et al. Differentiation, distribution and gammadelta T cell-driven regulation of IL-22 producing T cells in tuberculosis[J]. PLoS Pathog, 2010,6 (2) : e1000789.
  • 6叶宁华,曾今诚,罗勇强,林东子.肺结核患者血清IL-23和IL-22检测及临床意义[J].国际检验医学杂志,2014,35(7):817-818. 被引量:8
  • 7罗勇强,林东子,曾今诚.肺结核患者外周血Th17细胞亚群和血清IL-17A、IL-23含量检测[J].结核病与肺部健康杂志,2014,3(1):21-24. 被引量:7

二级参考文献23

  • 1Basu R, Hatton RD,Weaver CT. The Thl7 family: flexibility fol- lows function EJ. Immunol Rev, 2013,252(1) : 89-103.
  • 2Patel DD, Lee DM, Kolbinger F, et al. Effect of IL-17A blockade with seeukinumab in autoimmune diseasesEJ. Ann Rheum Dis, 2013,72 (2):116 123.
  • 3Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Thl 7 cyto- kine[-J. Immunol Rev,2013,252(1) : 116-132.
  • 4Winslow GM,Cooper A,Reiley W,et al. Early T-cell responses in tuberculosis immunityEJ. Immunol Rev, 2008,225 (2) : 284-299.
  • 5Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART:Iong term incidence and risk factors in a South African cohort[J]. AIDS,2005,19(18) :2109-2116.
  • 6Zhu J, Paul WE. CD4 T cells: fates, functions, and faults [J]. Blood,2008,112(5) ..1557-1569.
  • 7Kaufmann SH, Dorhoi A. Inflammation in tuberculosis: interac- tions, imbalances and interventions EJ. Curr ()pin Immunol, 2013,25(4) :441-449.
  • 8Croxford AL,Mair F, Becher B. IL-23:one cytokine in control of autoimmunity[J]. Eur J Immunol, 2012,42(9) .. 2263 2273.
  • 9Yen D,Cheung J,Scheerens H,et al. IL-23 is essential for T cell- mediated colitis and promotes inflammation via IL-17 and IL-6 J3. J Clin Invest, 2006,116(5) : 1310-1316.
  • 10Huang Z,van Velkinhurgh JC,Ni B,et al. Pivotal roles of the in- terleukin-23/T helper 17 cell axis in hepatitis BJ-J]. Liver Int, 2012,32 (6) 894-901.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部